EP Patent

EP0878197B1 — Compositions containing difluprednate

Assigned to Senju Pharmaceutical Co Ltd · Expires 2002-08-21 · 24y expired

What this patent protects

Patent listed against octreotide-acetate.

Drugs covered by this patent

octreotide-acetate (OCTREOTIDE ACETATE)

Patent Metadata

Patent number: EP0878197B1
Jurisdiction: EP
Classification: —
Expires: 2002-08-21
Drug substance claim: No
Drug product claim: No
Assignee: Senju Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.